Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
CompletedNCT04438265
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The main objective of the study is to assess whether the performance of type 2 quadratus lumborum block produces an improvement in the quality of life of the patient with osteoarthritis of the hip.
Study details
- Official title
- Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
- Conditions
- Hip Arthropathy
- Chronic Hip Pain
- Ultrasound Therapy
- Complications
- Interventions
- Drug: levobupivacaine
- Device: ultrasound device
- Sponsor
- Hospital Medina del Campo
- Collaborators
- Hospital Universitaio Getafe; Hospital Rio Hortega
- Start date
- 2020-09-01
- Primary completion
- 2022-09-01
- Sex
- All
- Age range
- from 18 Years to 85 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Sign informed consent (Annex 2) * Age 18-85 years * Cartilage injury (coxarthrosis) hip * Illness \<1 year of evolution * Patients with pain after treatment with physical therapy, exercises, NSAIDs. * EVN\> 5 Exclusion Criteria: * Refusal of the patient * Allergy to the drugs used * Contraindication for performing the technique * Intraarticular treatment in the previous 3 months * Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04438265